Treace Medical Concepts, Inc. (TMCI) Reports In-Line Q1 EPS

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.23), in-line with the analyst estimate of ($0.23). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $39.25 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c